Answers are grounded in this paper and cite their sources.
Cyclophosphamide is widely used in neoplastic and inflammatory diseases. Although several adverse events have been described with its use, acute and subacute interstitial pneumonitis leading to pulmonary fibrosis is rare and potentially fatal. This case report describes a 64-year-old man who, after the fifth chemotherapy cycle, developed a severe ARDS leading to pulmonary fibrosis in just 30 days.
No takes yet. Share an insight, caveat, or question.
Jorge Brieva (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: